Venture Certified
| 신기술기업(특허기술) | 2003-02-21 ~ 2005-02-20 | 031622031200208 | 2003-02-21 |
| 신기술기업(특허기술) | 2005-02-21 ~ 2007-02-20 | 051622031300161 | 2003-02-21 |
| 기술평가보증기업(기금) | 2007-02-21 ~ 2008-02-20 | 20070100086 | 2003-02-21 |
| 기술평가보증기업(기금) | 2008-02-21 ~ 2009-02-20 | 20080100191 | 2003-02-21 |
| 기술평가보증기업(기금) | 2009-02-21 ~ 2010-02-20 | 20090101028 | 2003-02-21 |
| 기술평가보증기업(기금) | 2010-02-21 ~ 2012-02-20 | 20100101007 | 2003-02-21 |
| 기술평가보증기업(기금) | 2012-02-21 ~ 2014-02-20 | 20120100455 | 2003-02-21 |
| 연구개발유형 | 2014-02-21 ~ 2016-02-20 | 20140100947 | 2003-02-21 |
| 연구개발유형 | 2016-02-21 ~ 2018-02-20 | 20160104647 | 2003-02-21 |
| 벤처투자유형 | 2018-02-21 ~ 2020-02-20 | 20180300117 | 2003-02-21 |
| 기술평가보증기업(기금) | 2020-02-21 ~ 2022-02-20 | 20200101743 | 2003-02-21 |
| 혁신성장유형 | 2022-02-21 ~ 2025-02-20 | 20220127030329 | 2003-02-21 |
| 혁신성장유형 | 2025-02-21 ~ 2028-02-20 | 20250305030112 | 2003-02-21 |
Revenue CAGR -8.9%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 251B | 307B | 302B |
| Operating Profit | -44B | -27B | -13B |
| Net Profit | -238B | -6.3B | 6.9B |
| Total Assets | 661B | 862B | 885B |
| Total Liabilities | 143B | 97B | 322B |
| Total Equity | 517B | 765B | 564B |
Operating Loss: Op. profit -44B
2 Consecutive Years of Net Loss
Debt Ratio Surge (+15pp YoY)
▼ 17.7%
▼ 116.9%
▼ 164.1%
▼ 20.6%
▼ 23415.8%
| Name | Position | Role |
|---|---|---|
| 홍준호 | 대표이사 | 대표 |
| Patent Title | Applicant | Application No. | Filing Date | Status |
|---|---|---|---|---|
| GLP-1 분비를 촉진하는 비피도박테리움 애니말리스 락티스 MG741 균주의 대사성 질환에 의한 근육 손실 예방 및 개선 치료용도 | 주식회사 메디오젠 | 1020250039650 | 2025-03-27 | 등록 |
| 에스트로겐 수용체를 활성화하는 리모실락토바실러스 루테리 MG5463을 포함하는 갱년기 증상의 예방, 개선 또는 치료용 조성물 | 주식회사 메디오젠 | 1020250032836 | 2025-03-13 | 공개 |
| 락토바실러스 퍼멘툼 MG4231 균주 및 락토바실러스 퍼멘툼 MG4244 균주를 포함하는 혼합 균주를 포함하는 다낭성 난소 증후군의 예방, 개선 또는 치료용 조성물 | 주식회사 메디오젠|고려대학교 산학협력단 | 1020250004650 | 2025-01-13 | 등록 |
| 비피도박테리움 애니말리스 락티스 MG741을 포함하는 다낭성 난소 증후군의 예방, 개선 또는 치료용 조성물 | 주식회사 메디오젠|고려대학교 산학협력단 | 1020250004649 | 2025-01-13 | 등록 |
| 락티카제이바실러스 람노서스 MG4644을 포함하는 신경염증성질환 및 인지기능 개선용 조성물 | 주식회사 메디오젠|건국대학교 글로컬산학협력단 | 1020240197362 | 2024-12-26 | 등록 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "충청북도 제천시",
"ceo_name": "홍준호",
"certificate": [
{
"cert_number": "031622031200208",
"changes": "",
"disclosure_date": "2003-02-21",
"first_cert_date": "2003-02-21",
"no": "1",
"type": "신기술기업(특허기술)",
"valid_period": "2003-02-21 ~ 2005-02-20"
},
{
"cert_number": "051622031300161",
"changes": "",
"disclosure_date": "2005-02-21",
"first_cert_date": "2003-02-21",
"no": "2",
"type": "신기술기업(특허기술)",
"valid_period": "2005-02-21 ~ 2007-02-20"
},
{
"cert_number": "20070100086",
"changes": "",
"disclosure_date": "2007-02-06",
"first_cert_date": "2003-02-21",
"no": "3",
"type": "기술평가보증기업(기금)",
"valid_period": "2007-02-21 ~ 2008-02-20"
},
{
"cert_number": "20080100191",
"changes": "",
"disclosure_date": "2008-01-24",
"first_cert_date": "2003-02-21",
"no": "4",
"type": "기술평가보증기업(기금)",
"valid_period": "2008-02-21 ~ 2009-02-20"
},
{
"cert_number": "20090101028",
"changes": "",
"disclosure_date": "2009-02-20",
"first_cert_date": "2003-02-21",
"no": "5",
"type": "기술평가보증기업(기금)",
"valid_period": "2009-02-21 ~ 2010-02-20"
},
{
"cert_number": "20100101007",
"changes": "",
"disclosure_date": "2010-02-17",
"first_cert_date": "2003-02-21",
"no": "6",
"type": "기술평가보증기업(기금)",
"valid_period": "2010-02-21 ~ 2012-02-20"
},
{
"cert_number": "20120100455",
"changes": "",
"disclosure_date": "2012-01-31",
"first_cert_date": "2003-02-21",
"no": "7",
"type": "기술평가보증기업(기금)",
"valid_period": "2012-02-21 ~ 2014-02-20"
},
{
"cert_number": "20140100947",
"changes": "",
"disclosure_date": "2014-02-05",
"first_cert_date": "2003-02-21",
"no": "8",
"type": "연구개발유형",
"valid_period": "2014-02-21 ~ 2016-02-20"
},
{
"cert_number": "20160104647",
"changes": "",
"disclosure_date": "2016-04-21",
"first_cert_date": "2003-02-21",
"no": "9",
"type": "연구개발유형",
"valid_period": "2016-02-21 ~ 2018-02-20"
},
{
"cert_number": "20180300117",
"changes": "",
"disclosure_date": "2018-02-22",
"first_cert_date": "2003-02-21",
"no": "10",
"type": "벤처투자유형",
"valid_period": "2018-02-21 ~ 2020-02-20"
},
{
"cert_number": "20200101743",
"changes": "",
"disclosure_date": "2020-02-21",
"first_cert_date": "2003-02-21",
"no": "11",
"type": "기술평가보증기업(기금)",
"valid_period": "2020-02-21 ~ 2022-02-20"
},
{
"cert_number": "20220127030329",
"changes": "",
"disclosure_date": "2022-01-27",
"first_cert_date": "2003-02-21",
"no": "12",
"type": "혁신성장유형",
"valid_period": "2022-02-21 ~ 2025-02-20"
},
{
"cert_number": "20250305030112",
"changes": "",
"disclosure_date": "2025-03-05",
"first_cert_date": "2003-02-21",
"no": "13",
"type": "혁신성장유형",
"valid_period": "2025-02-21 ~ 2028-02-20"
}
],
"company_name": "㈜메디오젠",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 31220756000,
"cost_of_sales": 26316021000,
"current_assets": 27981423000,
"current_liabilities": 31018997000,
"gross_profit": 3912154000,
"net_income": 689074000,
"net_income_bs": 479849000,
"non_current_assets": 60547894000,
"non_current_liabilities": 1137237000,
"non_operating_expenses": 4753988000,
"non_operating_income": 6739872000,
"operating_profit": -1296810000,
"revenue": 30228175000,
"sga_expenses": 5208964000,
"total_assets": 88529317000,
"total_equity": 56373083000,
"total_liabilities": 32156234000
},
"2023": {
"capital_stock": 52561162000,
"cost_of_sales": 28753494000,
"current_assets": 15510567000,
"current_liabilities": 7707800000,
"gross_profit": 1902948000,
"net_income": -632641000,
"net_income_bs": -777167000,
"non_current_assets": 70737184000,
"non_current_liabilities": 2036008000,
"non_operating_expenses": 3225690000,
"non_operating_income": 5341928000,
"operating_profit": -2748879000,
"revenue": 30656442000,
"sga_expenses": 4651827000,
"total_assets": 86247751000,
"total_equity": 76503943000,
"total_liabilities": 9743808000
},
"2024": {
"capital_stock": 50154908000,
"cost_of_sales": 24929617000,
"current_assets": 13479012000,
"current_liabilities": 11569761000,
"gross_profit": 135486000,
"net_income": -23842220000,
"net_income_bs": -22373343000,
"non_current_assets": 52579790000,
"non_current_liabilities": 2766174000,
"non_operating_expenses": 19673677000,
"non_operating_income": 219318000,
"operating_profit": -4387861000,
"revenue": 25065103000,
"sga_expenses": 4523347000,
"total_assets": 66058802000,
"total_equity": 51722867000,
"total_liabilities": 14335935000
}
},
"industry": "건강기능식품 제조업",
"investment": [
{
"amount": "1,000,012,000",
"changes": "1,000,012,000",
"date": "2015-12-30"
}
],
"main_products": "유산균 원료 및 유산균 함유 건강기능식품",
"phone": "043-644-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| Employment Insurance | 2026-02-25 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |